22nd Annual MedTech Venture & Partnering Conference
PANEL DISCUSSION: The Value of Representation in Healthtech
Moderated by Ingrid Ellerbe, Executive Director, DxD Healthtech
Within the framework of funding, innovation, organizational structure & regulatory requirements there exists a tremendous upside in leveraging equitable representation. Innovations that aim to improve the prevention, diagnosis, and treatment of human disease often intend to have broad societal benefit, but often, they fail to benefit everyone equally and worsen health. Let’s talk about how the healthtech innovation process, and the innovations that result, be made more equitable.
- Lisa Lavin, Founder, Chairman and CEO, Omcare
- Juan-Pablo Mas, Partner, Action Potential VC
- Sally Saba, MD, MBA, VP, Global Chief Inclusion and Diversity Officer and President of the Medtronic Foundation
- Kendal Whitlock, Head, Digital Optimization, RWE Clinical Trials, Walgreens Co.